Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab

NCT03107793 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd. as lead sponsor.

NCT NCT03107793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03107793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
Lead sponsor
Janssen-Cilag Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 19, 2017
Completion date
July 20, 2021
Enrollment
500 (actual)
Sites
107

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease